Hama Yukihiro, Urano Yasuteru, Koyama Yoshinori, Kamiya Mako, Bernardo Marcelino, Paik Ronald S, Krishna Murali C, Choyke Peter L, Kobayashi Hisataka
Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1088, USA.
Neoplasia. 2006 Jul;8(7):607-12. doi: 10.1593/neo.06268.
Intraperitoneal metastases commonly recur after surgery because small tumor foci escape detection within the complex anatomy of the peritoneal cavity and mesentery. Accurate localization of peritoneal implants during surgery could improve the resection of ovarian cancer and other malignancies, but few practical techniques to enhance detectability are currently available. Here, we describe a targeted molecular imaging method that employs fluorescently labeled avidin to detect submillimeter peritoneal implants of ovarian cancer in mice. After binding to surface lectins on the tumor, fluorescein-conjugated avidin enabled the spectral fluorescence imaging of disseminated peritoneal implants. High spatial resolution and high tumor-to-background ratio allowed the visualization of implants as small as 0.3 mm (with 100% sensitivity and specificity; n = 150) and the identification of even smaller lesions ex vivo. These results suggest that targeted molecular imaging with a fluorescence-labeled lectin-ligand system is a promising technique for the detection of disseminated submillimeter foci of cancer.
腹膜转移瘤在手术后常复发,因为在复杂的腹膜腔和肠系膜解剖结构中,小的肿瘤病灶难以被检测到。手术期间对腹膜种植灶进行精确定位可改善卵巢癌及其他恶性肿瘤的切除效果,但目前几乎没有实用的技术来提高其可检测性。在此,我们描述了一种靶向分子成像方法,该方法利用荧光标记的抗生物素蛋白来检测小鼠体内亚毫米级的卵巢癌腹膜种植灶。荧光素偶联的抗生物素蛋白与肿瘤表面的凝集素结合后,能够对播散性腹膜种植灶进行光谱荧光成像。高空间分辨率和高肿瘤与背景比使得小至0.3毫米的种植灶能够被可视化(灵敏度和特异性均为100%;n = 150),甚至能够在体外识别更小的病灶。这些结果表明,荧光标记的凝集素-配体系统靶向分子成像对于检测播散性亚毫米级癌灶是一种很有前景的技术。